8-K

Company

Cardiff Oncology, Inc.

Filed

April 12, 2022

Period of Report

April 7, 2022

Accession Number

0001628280-22-008987

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →